Feds, Mass. reach five year, $41.4B healthcare deal

 

Massachusetts and the federal government have reached a five-year, $41.4 billion healthcare accord, which will follow a three-year $26.75 billion waiver agreement that expired June 30, reports WBUR.

The new deal is about $640 million less per year compared to the most recent waiver, according to the story. However, government officials said the five-year duration offered more stability, and aligns with the state’s subsidized coverage programs with the Affordable Care Act.

Read more below:

Around the web

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.